Topic: Alzheimer’s disease
What is Donanemab?
Alzheimer’s disease, a debilitating neurodegenerative disorder, has long posed challenges for medical professionals and researchers. However, recent developments have brought hope with the approval of a new drug... Abnormality of Astrocytes and Alzheimer’s Disease
Despite the availability of new drugs for treating early Alzheimer’s, predicting who will eventually develop the disease remains a significant challenge. However, a recent study has shed light... Lecanemab Approved for Alzheimer’s Treatment
The US Food and Drug Administration (FDA) has approved lecanemab, a monoclonal antibody developed by Eisai and Biogen, for the treatment of Alzheimer’s disease. Lecanemab is the second...
September 21: World Alzheimer’s Day
World Alzheimer Day was observed across the world on September 21 with the objective of raising awareness of the disease, common symptoms and risk factors. Highlights Alzheimer disease...
Alzheimer Inhibitor developed by Jawaharlal Nehru Centre of Advanced Scientific Research
The scientists of Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR) operating under Department of Science and Technology has invented a natural product for Alzheimer disease. Significance Alzheimer’s...IIIT Hyderabad’s researchers creates first-ever ‘Indian Brain Atlas (IBA)’
The researchers at the International Institute of Information Technology-Hyderabad (IIITH) have created the first ever Indian Brain Atlas (IBA). They stated that the average Indian brain is smaller...
